Steroid complications in GVHD common, boost costs of careFebruary 19, 2021DLBCLLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
CAR T-cell products shine in real-world setting, reveal new insightsFebruary 18, 2021DLBCLLymphoma & Plasma Cell Disorders
How has the pandemic affected rural and urban cancer patients?February 18, 2021Patient & Survivor CareBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastrointestinal CancerGenitourinary CancerGynecologic Cancer
Chronic GVHD therapies offer hope for treating refractory diseaseFebruary 17, 2021Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersDLBCL
Prognostic gene signature identifies high- vs. low-risk DLBCL patientsFebruary 17, 2021DLBCLLymphoma & Plasma Cell Disorders
CXR-Net: An AI-based diagnostic tool for COVID-19February 9, 2021Patient & Survivor CareCOVID-19 UpdatesGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
FDA okays new CAR T-cell treatment for large B-cell lymphomasFebruary 8, 2021Lymphoma & Plasma Cell Disorders
COVID-19 vaccination in cancer patients: NCCN outlines prioritiesFebruary 1, 2021COVID-19 UpdatesPatient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic Cancer
Model predicts acute kidney injury in cancer patients a month in advanceFebruary 1, 2021Patient & Survivor CareGenitourinary CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersGynecologic CancerLung CancerGastrointestinal Cancer
COVID-19 vaccines and cancer patients: 4 things to knowDecember 21, 2020Patient & Survivor CareCOVID-19 UpdatesCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplantDecember 18, 2020Lymphoma & Plasma Cell Disorders
On the horizon: Asciminib, a new drug for treating r/r CMLDecember 16, 2020Lymphoma & Plasma Cell Disorders
Four-item prognostic index predicts survival in adult Burkitt lymphomaDecember 16, 2020Lymphoma & Plasma Cell Disorders
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myelomaDecember 15, 2020Lymphoma & Plasma Cell Disorders
Phase 1 study shows feasibility, safety, efficacy of STAR T cells for ALLDecember 14, 2020Lymphoma & Plasma Cell Disorders
